Evidence map›Paper›PMID 27999564›Full record

ReviewFrontiers in endocrinology2016

Distinct Hepatic Macrophage Populations in Lean and Obese Mice.

Rafael Mayoral Monibas, Andrew M F Johnson, Olivia Osborn, Paqui G Traves, Sushil K Mahata

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in endocrinology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Developmental origins of immunometabolic health.Immunometabolism (Cobham, Surrey) · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. miR-467 regulates inflammation and blood insulin and glucose.Journal of cellular and molecular medicine · 2021
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Adapting to obesity with adipose tissue inflammation.Nature reviews. Endocrinology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Rafael Mayoral MonibasMerck Research Laboratories, Kenilworth, NJ, USA; CIBERehd - Networked Biomedical Research Center, Hepatic and Digestive Diseases, Madrid, Spain.
Andrew M F JohnsonDepartment of Medicine, Division of Endocrinology and Metabolism, University of California San Diego , La Jolla, CA , USA.
Olivia OsbornDepartment of Medicine, Division of Endocrinology and Metabolism, University of California San Diego , La Jolla, CA , USA.
Paqui G TravesMolecular Neurobiology Laboratory, The Salk Institute , La Jolla, CA , USA.
Sushil K MahataMetabolic Physiology & Ultrastructural Biology Laboratory, Department of Medicine, VA San Diego Healthcare System, San Diego, CA, USA; Metabolic Physiology & Ultrastructural Biology Laboratory, Department of Medicine, University of California San Diego, La Jolla, CA, USA.
University of California, San Diego · USMerck & Co., Inc., Rahway, NJ, USA (United States) · USSalk Institute for Biological Studies · USVA San Diego Healthcare System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity is a complex metabolic disorder associated with the development of non-communicable diseases such as cirrhosis, non-alcoholic fatty liver disease, and type 2 diabetes. In humans and rodents, obesity promotes hepatic steatosis and inflammation, which leads to increased production of pro-inflammatory cytokines and acute-phase proteins. Liver macrophages (resident as well as recruited) play a significant role in hepatic inflammation and insulin resistance (IR). Interestingly, depletion of hepatic macrophages protects against the development of high-fat-induced steatosis, inflammation, and IR. Kupffer cells (KCs), liver-resident macrophages, are the first-line defense against invading pathogens, clear toxic or immunogenic molecules, and help to maintain the liver in a tolerogenic immune environment. During high fat diet feeding and steatosis, there is an increased number of recruited hepatic macrophages (RHMs) in the liver and activation of KCs to a more inflammatory or M1 state. In this review, we will focus on the role of liver macrophages (KCs and RHMs) during obesity.

Indexed as

hepatocytesimmunometabolisminflammationinsulin resistanceKupffer cellsobesity

Identifiers

PMID27999564
PMCPMC5138231
OpenAlexW2560390522

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.